Lumos Pharma

Phase 2

Austin, United StatesFounded 2011lumos-pharma.com

Lumos Pharma - Our Focus Is Rare Disease

Market Cap

Private

Pipeline

—

Patents

—

Publications

—

Private Company

Total funding raised: $110M

About

Lumos Pharma - Our Focus Is Rare Disease

Small Molecules

Funding History

3

Total raised:$110M

IPO$60MUndisclosedJan 29, 2021

Series B$35MNew Enterprise AssociatesJun 15, 2015

Series A$15MSante VenturesDec 15, 2011